Global Trikafta Patent Market Analysis, Application & Forecast To 2021-2028
Submitted by James Grey | November 1, 2021, 04:40:58 | Business
The successful mapping of human genome and advances in molecular technology has led to evolution of targeted therapies. The identification of cystic fibrosis transmembrane conductor regulator (CFTR) gene and its potential role in the progression of cystic fibrosis has surged the research and development of targeted drugs towards CFTR genes.
Source: https://www.bharatbook.com/report/956608/trikafta-patent-sales-clinical-trials-outlook
